Test Agonist | Potency Ratio | (95% CL) | Potency Ratio | (95% CL) |
---|---|---|---|---|
0.003 Etorphine Alone | 0.003 Etorphine + 3.0 LY235959 | |||
Etorphine | 1.0 | (0.8–1.3) | 0.9 | (0.5–1.8) |
Morphine | 2.2 | (1.5–3.1) | 1.2 | (0.9–1.6) |
Dezocine | 3.4 | (1.9–6.2) | 1.2 | (0.5–2.9) |
10.0 Morphine Alone | 10.0 Morphine + 3.0 LY235959 | |||
---|---|---|---|---|
Etorphine | 2.5 | (1.9–3.4) | 1.4 | (1.1–2.0) |
Morphine | 2.9 | (2.0–4.4) | 1.2 | (0.9–1.6) |
Dezocine | —2-a | — | 4.0 | (1.8–9.5) |
3.0 Dezocine Alone | 3.0 Dezocine + 3.0 LY235959 | |||
---|---|---|---|---|
Etorphine | 4.12-b | (2.8–6.1) | 2.4 | (1.4–3.7) |
Morphine | 3.5 | (2.5–5.0) | 1.7 | (1.1–2.6) |
Dezocine | 9.62-b | (4.9–18.9) | 2.8 | (1.5–5.5) |
Labels to the left of the columns represent the test drug for a group (Test Agonist). Labels in the columns represent the chronic treatment condition. Values in parentheses represent the 95% confidence limits (CL) for each potency ratio.